Nihal Batla, from Bhiwandi in adjoining Thane district, was fighting the disease that aged him eight times faster than normal.
He was at his grandparents' house at Karimnagar in Telangana to attend a family wedding. On Monday evening, he felt dehydrated due to the scorching heat and had to be rushed to a private hospital for treatment.
Within a few hours, he passed away, family sources said.
His last rites were performed in Karimnagar yesterday.
The boy, who was part of a clinical trial for Lonafarnib drug in Boston to test if the drug could delay ageing, had posted his pictures on Facebook and Twitter to reach out to parents, specially in rural areas.
Progeria or Hutchinson-Gilford Progeria syndrome, from which Nihal suffered, causes accelerated ageing in children, leading to premature death mostly due to heart attacks.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
